Lipocine Inc. 8-K

What Happened

• Lipocine Inc. (LPCN) filed a Form 8-K on May 7, 2026 to announce its financial and operational results for the quarter ended March 31, 2026. The company furnished a press release with those results as Exhibit 99.1 to the 8-K; the press release is incorporated by reference into the filing.

Key Details

• Filing date: May 7, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Reporting period: Quarter ended March 31, 2026.
• Exhibit provided: Press Release announcing financial results (Exhibit 99.1).
• Interactive data: Cover Page Interactive Data File included as Exhibit 104 (Inline XBRL).

Why It Matters

• This 8-K signals that Lipocine has published its latest quarterly operating and financial results; investors should review the furnished press release (Exhibit 99.1) for specific metrics such as revenue, net income/loss, cash balance, and operating highlights.
• The 8-K itself does not include the numeric results in-line; the press release and any subsequent SEC filings (e.g., 10-Q) will provide the detailed figures and context investors need to assess company performance.